D
David Pépin
Researcher at Harvard University
Publications - 61
Citations - 2683
David Pépin is an academic researcher from Harvard University. The author has contributed to research in topics: Anti-Müllerian hormone & Medicine. The author has an hindex of 17, co-authored 48 publications receiving 1952 citations. Previous affiliations of David Pépin include Massachusetts Eye and Ear Infirmary & Ottawa Hospital Research Institute.
Papers
More filters
Journal ArticleDOI
Homogenization of regional river dynamics by dams and global biodiversity implications.
TL;DR: Long-term streamflow records are used on intermediate-sized rivers across the continental United States to show that dams have homogenized the flow regimes on third- through seventh-order rivers in 16 historically distinctive hydrologic regions over the course of the 20th century.
Journal ArticleDOI
Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic.
Andrea G. Edlow,Jonathan Z. Li,Ai-ris Y. Collier,Caroline Atyeo,Kaitlyn E. James,Adeline A. Boatin,Kathryn J. Gray,Evan A. Bordt,Lydia L. Shook,Lael M. Yonker,Alessio Fasano,Khady Diouf,Natalie Croul,Samantha Devane,Laura J. Yockey,Rosiane Lima,Jessica E. Shui,Juan D. Matute,Paul H. Lerou,Babatunde Akinwunmi,Aaron G. Schmidt,Aaron G. Schmidt,Jared Feldman,Blake M. Hauser,Timothy M. Caradonna,Denis De la Flor,Paolo D'Avino,James Regan,Heather Corry,Kendyll Coxen,Jesse Fajnzylber,David Pépin,Michael S. Seaman,Dan H. Barouch,Dan H. Barouch,Bruce D. Walker,Xu G. Yu,Xu G. Yu,Anjali J Kaimal,Drucilla J. Roberts,Galit Alter +40 more
TL;DR: In this paper, a cohort study was conducted among pregnant women presenting for care at 3 tertiary care centers in Boston, Massachusetts, where women with reverse transcription-polymerase chain reaction (RT-PCR) results positive for SARS-CoV-2 were recruited from April 2 to June 13, 2020 and follow-up occurred through July 10, 2020.
Journal ArticleDOI
Compromised SARS-CoV-2-specific placental antibody transfer.
Caroline Atyeo,Caroline Atyeo,Krista M. Pullen,Evan A. Bordt,Stephanie Fischinger,Stephanie Fischinger,John F. Burke,Ashlin R. Michell,Matthew D. Slein,Carolin Loos,Carolin Loos,Lydia L. Shook,Adeline A. Boatin,Laura J. Yockey,David Pépin,Marie-Charlotte Meinsohn,Ngoc Minh Phuong Nguyen,Maeva Chauvin,Drucilla J. Roberts,Ilona T. Goldfarb,Juan D. Matute,Kaitlyn E. James,Lael M. Yonker,Lisa M. Bebell,Anjali J Kaimal,Kathryn J. Gray,Douglas A. Lauffenburger,Andrea G. Edlow,Galit Alter +28 more
TL;DR: Systems serology characterized the Fc-profile of influenza, pertussis, and SARS-CoV-2-specific antibodies transferred across the placenta to point to unexpected compensatory mechanisms to boost immunity in neonates, providing insights for maternal vaccine design.
Journal ArticleDOI
AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy
Motohiro Kano,Amanda Sosulski,Li Hua Zhang,Hatice D. Saatcioglu,Dan Wang,Nicholas Nagykery,Mary E. Sabatini,Guangping Gao,Patricia K. Donahoe,David Pépin +9 more
TL;DR: It is shown that long-term parenteral administration of superphysiological doses of MIS, using either an adeno-associated virus serotype 9 (AAV9) gene therapy vector or recombinant protein, resulted in a complete arrest of folliculogenesis in mice, representing a unique mechanism of contraception that spares the pool of quiescent primordial follicles (ovarian reserve).
Journal ArticleDOI
Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance
Katia Meirelles,Leo Andrew Benedict,David Dombkowski,David Pépin,Frederic I. Preffer,José A. Teixeira,Pradeep S. Tanwar,Robert H. Young,David T. MacLaughlin,Patricia K. Donahoe,Xiaolong Wei +10 more
TL;DR: The results suggest that chemotherapeutics may be stimulative to cancer stem cells and that selective inhibition of these cells by treating with MIS or targeting LIN28 should be considered in the development of therapeutics.